Today: 15 January 2026
Subscribe

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18
22 December 2025
····
AST SpaceMobile (ASTS) Stock in Focus: BlueBird-6 Launch Countdown, Fresh Valuation Debate, and Wall Street Targets (Dec. 22, 2025)

AST SpaceMobile (ASTS) Stock in Focus: BlueBird-6 Launch Countdown, Fresh Valuation Debate, and Wall Street Targets (Dec. 22, 2025)

AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the market’s spotlight on December 22, 2025, with investors zeroed in on one near-term catalyst: the launch of BlueBird 6, the company’s first next‑generation “Block 2” satellite. Today’s conversation around ASTS stock
22 December 2025
····
Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI (DVLT) Stock News Today: New Blockchain Patents, 2026 Revenue Forecasts, and the Catalysts Moving Shares (Dec. 22, 2025)

Datavault AI Inc. (NASDAQ: DVLT) is back in the spotlight on December 22, 2025 after announcing two newly issued U.S. patents tied to blockchain-driven content licensing and tokenized monetization—an intellectual-property update that fits squarely into the company’s larger pitch: turning
22 December 2025
····
Firefly Aerospace Stock (NASDAQ: FLY) News Today: Fresh Catalysts, Analyst Forecasts, and Key Risks to Watch (Dec. 22, 2025)

Firefly Aerospace Stock (NASDAQ: FLY) News Today: Fresh Catalysts, Analyst Forecasts, and Key Risks to Watch (Dec. 22, 2025)

December 22, 2025 — Firefly Aerospace Inc. (NASDAQ: FLY) is back in the “space stocks” spotlight as investors weigh a mix of new leadership, recent commercial and defense momentum, new/updated analyst coverage, and a growing drumbeat of securities lawsuit deadline
22 December 2025
····
ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

ABIVAX (ABVX) Stock Surges on Eli Lilly Takeover Talk as Nasdaq Biotech Index Inclusion Kicks In — News, Forecasts and Outlook (Dec. 22, 2025)

December 22, 2025 — ABIVAX Société Anonyme (ticker ABVX on Nasdaq and Euronext Paris) is back in the spotlight today, with traders juggling two storylines that can move a biotech stock fast: renewed takeover speculation involving Eli Lilly and Abivax’s
22 December 2025
····
1 … 693 694 695 696 697 … 2,077
Go toTop